42373-30-8 Usage
Description
4-AMINO-3-FORMYLPYRIDINE, also known as 4-Aminonicotinaldehyde, is an organic compound with the molecular formula C6H6N2O. It is a derivative of pyridine, featuring an amino group at the 4th position and a formyl group at the 3rd position. 4-AMINO-3-FORMYLPYRIDINE is known for its potential applications in the pharmaceutical and chemical industries due to its unique structure and reactivity.
Uses
Used in Pharmaceutical Industry:
4-AMINO-3-FORMYLPYRIDINE is used as a reagent for the preparation of 2,3-disubstituted 1,6-naphthyridines. These compounds are considered potential diuretic agents, which can be beneficial in the treatment of various medical conditions related to fluid retention and imbalance of electrolytes in the body.
Check Digit Verification of cas no
The CAS Registry Mumber 42373-30-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,3,7 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 42373-30:
(7*4)+(6*2)+(5*3)+(4*7)+(3*3)+(2*3)+(1*0)=98
98 % 10 = 8
So 42373-30-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N2O/c7-6-1-2-8-3-5(6)4-9/h1-4H,(H2,7,8)
42373-30-8Relevant articles and documents
Synthesis of 6,6'-diamino-2,2'-biquinoline and 2,2'-bi-1,6- naphthyridine
Janiak, Christoph,Deblon, Stephan,Uehlin, Lars
, p. 959 - 964 (1999)
High-yield synthesis and characterization of the new heterocycles 6,6'- diamino-2,2'-biquinoline (3), 6,6'-bis(N,N-dimethyl-amino)-2,2'-biquinoline (4), and 2,2'-bi-1,6-naphthyridine (5) are described. The preparation of 3 and 4 is based on the coupling of 2-amino-6-chloroquinoline and 2-chloro-6- dimethylaminoquinoline in the presence of NiCl2·6H2O/PPh3/Zn in DMF (NiCRA). Compound 5 was synthesized through a condensation reaction of 4- aminopyridine-3-carbaldehyde and butane-2,3-dione.
SUBSTITUTED HETEROCYCLIC AZA DERIVATIVES
-
, (2013/03/26)
The invention relates to heterocyclic aza derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Kinase inhibitors
-
, (2008/06/13)
Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.